Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging.
Ben-Meir A, Burstein E, Borrego-Alvarez A, Chong J, Wong E, Yavorska T, Naranian T, Chi M, Wang Y, Bentov Y, Alexis J, Meriano J, Sung HK, Gasser DL, Moley KH, Hekimi S, Casper RF, Jurisicova A. · 2015
Read Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging. by Ben-Meir A, Burstein E, Borrego-Alvarez A, Chong J, Wong E, Yavorska T, Naranian T, Chi M, Wang Y, Bentov Y, Alexis J, Meriano J, Sung HK, Gasser DL, Moley KH, Hekimi S, Casper RF, Jurisicova A. (2015) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4568976.txt.
Introduction
Assaf Ben-Meir leads a twelve-author team restoring egg cell youth with a dietary compound, in Aging Cell in 2015. Women's fertility falls steeply in the fourth decade of life as egg quality and supply drop. The causes of that aging were elusive. The team traced it to the egg's mitochondria, its energy units, which falter with age.
Old eggs in mice and humans made less of two enzymes needed to build coenzyme Q10, a molecule the energy chain requires, and their energy output fell. Giving CoQ10 reversed the decline in egg quality and number in older mice. Knocking out one enzyme in young eggs copied the aged state, down to infertility and early ovarian failure, and CoQ10 prevented that failure.
Catalog record
| CREATOR | Ben-Meir A, Burstein E, Borrego-Alvarez A, Chong J, Wong E, Yavorska T, Naranian T, Chi M, Wang Y, Bentov Y, Alexis J, Meriano J, Sung HK, Gasser DL, Moley KH, Hekimi S, Casper RF, Jurisicova A. |
|---|---|
| YEAR | 2015 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 50 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Coenzyme Q10 restores oocyte mitochondrial function and fertility during reproductive aging By Assaf Ben-Meir, Eliezer Burstein, Aluet Borrego-Alvarez, Jasmine Chong, Ellen Wong, Tetyana Yavorska, Taline Naranian, Maggie Chi, Ying Wang, Yaakov Bentov, Jennifer Alexis, James Meriano Published in: Aging Cell DOI: 10.1111/acel.12368 ABSTRACT Female reproductive capacity declines dramatically in the fourth decade of life as a result of an age-related decrease in oocyte quality and quantity. The primary causes of reproductive aging and the molecular factors responsible for decreased oocyte quality remain elusive. Here, we show that aging of the female germ line is accompanied by mitochondrial dysfunction associated with decreased oxidative phosphorylation and reduced Adenosine tri-phosphate (ATP) level. Diminished expression of the enzymes responsible for CoQ production, Pdss2 and Coq6, was observed in oocytes of older females in both mouse and human. The age-related decline in oocyte quality and quantity could be reversed by the administration of CoQ10. Oocyte-specific disruption of Pdss2 recapitulated many of the mitochondrial and reproductive phenotypes observed in the old females including reduced ATP production and increased meiotic spindle abnormalities, resulting in infertility. Ovarian reserve in the oocyte-specific Pdss2-deficient animals was diminished, leading to premature ovarian failure which could be prevented by maternal dietary administration of CoQ10. We conclude that impaired mitochondrial performance created by suboptimal CoQ10 availability can drive age-associated oocyte deficits causing infertility. INTRODUCTION Female fertility is one of the first physiological functions adversely affected by aging. Female fecundity starts declining at age 32 and decreases more rapidly after age 37 (O’Connor et al., 1998). This decrease in the probability of conception occurs in spite of continuing ovulatory cycles (te Velde & Pearson, 2002). Although neuroendocrine and uterine factors contribute to the age-related decline of successful pregnancy, the consistent live-birth rate of pregnancies from oocyte donation in aging women suggests that the decline in oocyte quality is the major contributing factor responsible for infertility with aging. Maternal aging is known to trigger a series of molecular alterations that drive the defects in chromatid separation (Chiang et al., 2011) and chromosome decondensation, as well as spindle detachment causing chromosomal misalignment (Battaglia et al., 1996; Liu & Keefe, 2002). However, only a few targets responsible for these changes have been identified, and no treatment thus far has been successful in improving the chances of a live birth in women of advanced maternal age. Decline in female reproductive capacity with aging is accompanied by depletion of ovarian reserve. In human, progressive loss of ovarian follicles is nonlinear and becomes accelerated with age, especially after 38 years of age (Faddy, 2000). Molecular pathways behind increased loss of germ cells in aged ovaries are poorly understood. Increased DNA damage due to less active DNA repair machinery is one possible trigger for oocyte loss (Titus et al., 2013). The complex process of oocyte maturation prior to ovulation involves nuclear, cytoplasmic, and epigenetic changes culminating with the formation of the meiotic spindle. All of these processes require energy, which is provided by mitochondria mostly via oxidative phosphorylation – OXPHOS (Dumollard et al., 2007), as the alternative energetic process of glycolysis in the oocyte is limited due to low expression of phosphofructokinase (Leese & Barton, 1984). The bioenergetic state of the oocyte influences its developmental competence with correlations between implantation potential, ATP content (Van Blerkom et al., 1995), and mitochondrial membrane potential (Wilding et al., 2001). Furthermore, interference with OXPHOS or with mitochondrial function leads to arrest of oocyte maturation, chromosomal misalignment, and compromised embryo development (Takeuchi et al., 2005; Thouas et al., 2006; Wyman et al., 2008). ATP production via OXPHOS involves the action of the electron transfer chain consisting of five complexes located on the inner mitochondrial membrane. Complexes I and II oxidize products of the tricarboxylic acid (TCA cycle) and transfer the electrons to ubiquinone, also known as coenzyme Q (CoQ). The electrons are transferred to complexes III and IV, creating a proton gradient which culminates in the generation of ATP by complex V. CoQ is pleiomorphic having critical antioxidant properties, controlling cellular redox, altering various signaling pathways, and influencing transcriptional activity of cells and is required for the activity of succinate dehydrogenase (Crane, 2001; Quinzii et al., 2010). Several observational studies demonstrated a tissue-specific decline in CoQ levels with age (Kalen et al., 1989; Miles et al., 2004). De novo CoQ production involves a complex but poorly understood biochemical pathway, depending on the activity of at least 10 different enzymes. The benzoquinone ring of CoQ is synthesized from the amino acid tyrosine or phenylalanine, and the tail is produced from acetyl-CoA by the mevalonate pathway through the action of tetrameric decaprenyl diphosphate synthase, encoded by the Pdss1 and Pdss2 genes. Upon condensation of the ring with the polyprenyl tail by the COQ2 enzyme, the ring structure is modified by decarboxylation, hydroxylation, and methylation, mediated by enzymes encoded by Coq 3, 6, and 7. CoQ proteins form a large mitochondrial complex (Tran & Clarke, 2007), and the presence of all protein components is required to maintain its stability (Wang & Hekimi, 2013). The aim of this study was to determine whether impaired oocyte mitochondrial function could be improved by supplementation with mitochondrial energy-production stimulants and to determine whether oocyte-specific inhibition of CoQ synthesis could recapitulate the reproductive abnormalities seen with aging. RESULTS As maternal aging is accompanied by reduction of mitochondrial function in oocytes (Kujjo et al., 2013), we treated aged dams with known stimulators of mitochondrial bioenergetics, CoQ10, alpha lipoic acid, and resveratrol. CoQ10 significantly improved ovulation rates in this model (Fig. S1A). Thus, we focused our further experiments to determine whether CoQ10 can ameliorate other aging-mediated phenotypes in the female germ line. After confirming that ovarian response was improved in a larger cohort of females treated with CoQ10 (Fig.1), we evaluated whether ovarian reserve and breeding performance with aging can also be improved. While substantial ovarian reserve was lost during a 3-month treatment (from 9 to 12 months Fig. S1B), ovarian histomorphometry confirmed increased numbers of primordial, preantral, and antral follicles in the CoQ10-treated group compared to the aged-matched vehicle-treated cohort (Fig.1A). As preservation of ovarian reserve does not necessarily mean production of better quality oocytes, we subjected females to a breeding trial. The reduced litter size observed in the old vehicle-treated dams was normalized with CoQ10 (Fig.1C). Thus, CoQ10 supplementation not only preserved the ovarian follicle pool, but also facilitated ovulation of gametes able to support normal development. [Figure: Impact of CoQ10 treatment on ovarian reserve and breeding performance in an aged mouse model. (A) Ovarian reserve was significantly higher in old vehicle mice treated with CoQ10 for a period of 15 weeks (n = 9/age and treatment) evidenced by significantly higher number of resting primordial and growing secondary follicles. Values represent average follicle numbers ± SEM. Images of stimulated ovaries from each group are shown on the right – magnification 50×. (B) Number of ovulated oocytes collected after hormonal stimulation of young (n = 20), old vehicle-treated (n = 16), and old CoQ10-treated dams (n = 16). Values represent average number of oocytes per female ± SEM. (C) Litter size in young (n = 39), old vehicle-treated (n = 15), and old CoQ10-treated mice (n = 11). The number of live pups born to